17 Nov 2019 | 10:15 AM
 

Glenmark Pharmaceuticals Ltd. Share Price Live (BSE)
0

BSE Code: 532296 | NSE Symbol: GLENMARK
301.20
18.90
(6.70 %)
15 Nov 2019 | 04:01 PM
Change company
  • Open (Rs)
    298.00
  • Prev. close (Rs.)
    282.30
  • High (Rs.)
    305.40
  • Low (Rs.)
    290.20
  • 52W H (Rs.)
    706.90
  • 52W L (Rs.)
    267.30
  • Volume
    676118
  • MCap (Rs in Cr.)
    8,498.91
651.6
12.15
(1.90 %)
  • Open (Rs)
    640.05
  • High (Rs)
    652.50
  • Low (Rs)
    639.00
  • Prev. close(Rs)
    639.45
  • Contracts Tra.
    14,10,000
  • Turnover (Cr.)
    91
  • Open Interest
    9,00,000
  • Open Int. chg
    -9,40,000.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
32.78
Operating Margin (%)
16.07
Gross Profit Margin (%)
12.77
Net Profit Margin (%)
9.37
Total Debt/Equity
0.69
Dividend payout Ratio (Net Profit)
7.35
Earning Retention Ratio
91.03

News

18 Oct 2019 - 14:50:00-As of September 2019 46.59% is owned by Indian Promoters and 53.42% by Public...
17 Oct 2019 - 11:24:00-Drug firm Glenmark Pharmaceuticals on Thursday said it has received final approval from the US healt...
09 Oct 2019 - 09:33:00-Drug maker Glenmark Pharmaceuticals Inc...
07 Oct 2019 - 12:58:00-Drug firm Glenmark Pharmaceuticals on Saturday said it has received a warning letter from the US hea...

Announcements

14-Nov-2019
Glenmark Pharma - Financial Result Updates
14-Nov-2019
Glenmark Pharma - ESOP/ESOS/ESPS
14-Nov-2019
Glenmark Pharma - Unaudited Financial Results For The Second Quarter And Half Year Ended September 30 2019
14-Nov-2019
Glenmark Pharma - Grant Of ESOP
11-Nov-2019
Glenmark Pharma - Press Release

Religare Research

28 Feb 2019 | 10:15 AM
• Agri markets kept trading with high volatility with no strong directions, even as prices seem to f...
04 Feb 2019 | 11:57 AM
Agri Fundamental & Technical Report
21 Jan 2019 | 07:35 PM
Weekly report
07 Jan 2019 | 06:56 PM
Gold prices fell on Friday, pulling back from more than a six-month peak hit earlier in the session,...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
10,00,000 115.06 72.25 0.19
10,00,000 115.06 59.07 0.19
10,00,000 115.06 218.96 0.19
10,00,000 115.06 232.63 0.20
10,00,000 115.06 77.96 0.20

Shareholding Pattern

       
Promotors46.58%
Mutual Funds/UTI4.31%
FI/Banks3.12%
Insurance3.12%
FII31.37%
Government0.00%
Others4.89%

Peer Group

Company Intraday Graph
 Procter & Gamble Health Ltd.
4,291.65(-0.08)
3302
 AstraZeneca Pharma India Ltd.
2,626.00(-0.98)
3274
 Metropolis Healthcare Ltd.
1,369.55(-2.16)
20203
 Ajanta Pharma Ltd.
973.00(-0.24)
3790

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Glenmark Pharmaceuticals Ltd.14.75-59.90-288.40
NIFTY(S&P CNX)467.15847.65738.45
BSE SENSEX1,850.603,006.363,241.81
BSE 500655.151,101.46838.89

Corporate Details

Key Personal
B E Saldanha
Non Executive Director
Bernard Munos
Non Exe. & Ind. Director
Brian W Tempest
Non Exe. & Ind. Director
Key Address
Registered Office
B/2 Mahalaxmi Chambers 22 Bhulabhai Desai Road,Mumbai,Maharashtra

Tel:022-40189999 40189879, Fax:022-40189986

csr@glenmarkpharma.com
http://www.glenmarkpharma.com
Registrar Office
Karvy Fintech Pvt. Ltd.
Add. :Karvy Selenium Tower B Plot No. 31-32 Gachibowli Financial District Nanakramguda Serilingampally Mandal